MA53868A - Composés agonistes du récepteur bêta des hormones thyroïdiennes - Google Patents

Composés agonistes du récepteur bêta des hormones thyroïdiennes

Info

Publication number
MA53868A
MA53868A MA053868A MA53868A MA53868A MA 53868 A MA53868 A MA 53868A MA 053868 A MA053868 A MA 053868A MA 53868 A MA53868 A MA 53868A MA 53868 A MA53868 A MA 53868A
Authority
MA
Morocco
Prior art keywords
receptor agonist
thyroid hormone
beta receptor
agonist compounds
hormone beta
Prior art date
Application number
MA053868A
Other languages
English (en)
French (fr)
Inventor
Randall Halcomb
Thorsten A Kirschberg
F Anthony Romero
Yingzi Xu
Original Assignee
Terns Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terns Inc filed Critical Terns Inc
Publication of MA53868A publication Critical patent/MA53868A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA053868A 2018-10-12 2019-10-10 Composés agonistes du récepteur bêta des hormones thyroïdiennes MA53868A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862745195P 2018-10-12 2018-10-12

Publications (1)

Publication Number Publication Date
MA53868A true MA53868A (fr) 2021-08-18

Family

ID=70161488

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053868A MA53868A (fr) 2018-10-12 2019-10-10 Composés agonistes du récepteur bêta des hormones thyroïdiennes

Country Status (9)

Country Link
US (2) US11203587B2 (cg-RX-API-DMAC7.html)
EP (1) EP3863635A4 (cg-RX-API-DMAC7.html)
JP (2) JP7595004B2 (cg-RX-API-DMAC7.html)
CN (1) CN112839655B (cg-RX-API-DMAC7.html)
AR (1) AR116694A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019357618B2 (cg-RX-API-DMAC7.html)
MA (1) MA53868A (cg-RX-API-DMAC7.html)
TW (2) TWI884745B (cg-RX-API-DMAC7.html)
WO (1) WO2020077123A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121081472A (zh) 2018-12-13 2025-12-09 拓臻股份有限公司 一种THRβ受体激动剂化合物及其制备方法和用途
WO2020227549A1 (en) 2019-05-08 2020-11-12 Aligos Therapeutics, Inc. MODULATORS OF THR-β AND METHODS OF USE THEREOF
CA3154488A1 (en) 2019-08-23 2021-03-04 Terns Pharmaceuticals, Inc. Thyroid hormone receptor beta agonist compounds
CA3154391A1 (en) 2019-09-12 2021-03-18 Terns Pharmaceuticals, Inc. Thyroid hormone receptor beta agonist compounds
CN113278013B (zh) * 2020-02-20 2022-09-23 昆药集团股份有限公司 2,6-二取代的1,2,4-三嗪-3,5-二酮化合物及其制备方法和应用
WO2021244582A1 (zh) * 2020-06-02 2021-12-09 成都康弘药业集团股份有限公司 新型甲状腺激素β受体激动剂
WO2022053028A1 (zh) * 2020-09-10 2022-03-17 南京明德新药研发有限公司 1,2,4-三嗪-3,5(2h,4h)-二酮类化合物及其应用
CN112645936B (zh) * 2020-12-17 2022-03-01 山东第一医科大学(山东省医学科学院) 取代的哒嗪酮类化合物及其用途
JP2024510935A (ja) * 2021-03-03 2024-03-12 ターンズ・ファーマシューティカルズ・インコーポレイテッド 甲状腺ホルモン受容体ベータアゴニスト化合物
PE20252787A1 (es) 2023-04-07 2025-12-22 Terns Pharmaceuticals Inc Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica
WO2026092583A1 (en) 2024-10-30 2026-05-07 Ascletis Pharma (China) Co., Limited Thr-beta modulators, alone or in combination with glp-1r\gipr\gcgr modulators for the treatment of metabolic diseases and alopecia areata diseases

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787652B1 (en) 1999-09-30 2004-09-07 Pfizer, Inc. 6-Azauracil derivatives as thyroid receptor ligands
DE60020786T2 (de) 1999-09-30 2006-03-23 Pfizer Products Inc., Groton 6-Azauracilderivate als Liganden der Thyroidrezeptoren
CA2473162A1 (en) 2002-01-30 2003-08-07 Kissei Pharmaceutical Co., Ltd. Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
WO2003094845A2 (en) 2002-05-08 2003-11-20 Bristol-Myers Squibb Company Pyridine-based thyroid receptor ligands
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
FR2882750B1 (fr) * 2005-03-03 2007-05-11 Pierre Fabre Medicament Sa Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
GB0513692D0 (en) 2005-07-04 2005-08-10 Karobio Ab Novel pharmaceutical compositions
ATE480524T1 (de) * 2005-07-21 2010-09-15 Hoffmann La Roche Pyridazinonderivate als schilddrüsenhormon- rezeptoragonisten
FR2933979B1 (fr) 2008-07-15 2012-08-24 Pf Medicament Derives de triazines et uraciles, leur preparation et leur application en therapeutique humaine
KR101396606B1 (ko) 2009-04-20 2014-05-16 미쓰비시 타나베 파마 코퍼레이션 신규 갑상선 호르몬 β 수용체 작동약
WO2011038207A1 (en) 2009-09-25 2011-03-31 Metabasis Therapeutics, Inc. Phosphorus-containing thyroid hormone receptor agonists and methods of use
EA023521B1 (ru) * 2011-11-14 2016-06-30 Сефалон, Инк. ПРОИЗВОДНЫЕ УРАЦИЛА В КАЧЕСТВЕ ИНГИБИТОРОВ AXL И c-MET КИНАЗЫ
CN103130723B (zh) 2011-11-30 2015-01-14 成都地奥制药集团有限公司 一种多聚(adp-核糖)聚合酶抑制剂
CN107074823B (zh) * 2014-09-05 2021-05-04 基因泰克公司 治疗性化合物及其用途
MX394463B (es) 2016-10-18 2025-03-19 Madrigal Pharmaceuticals Inc Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta.
CN109574995B (zh) 2018-01-23 2020-07-24 深圳市塔吉瑞生物医药有限公司 取代的哒嗪酮化合物
ES3029158T3 (en) 2018-06-12 2025-06-23 Xizang Haisco Pharmaceutical Co Ltd Thyroid hormone receptor agonists and uses thereof
WO2020041741A1 (en) 2018-08-24 2020-02-27 Terns, Inc. Thyroid hormone receptor beta agonist compounds
CN119552152A (zh) 2018-10-12 2025-03-04 益方生物科技(上海)股份有限公司 甲状腺激素受体激动剂
CN121081472A (zh) 2018-12-13 2025-12-09 拓臻股份有限公司 一种THRβ受体激动剂化合物及其制备方法和用途
CN111484481A (zh) 2019-01-26 2020-08-04 察略盛医药科技(上海)有限公司 哒嗪酮类衍生物、其制备方法及其在医药上的用途
CN119431265A (zh) 2019-02-21 2025-02-14 南京瑞捷医药科技有限公司 一种作为甲状腺激素受体激动剂的化合物
WO2020239076A1 (zh) 2019-05-29 2020-12-03 南京明德新药研发有限公司 作为甲状腺素受体-β激动剂的哒嗪酮类衍生物及其应用

Also Published As

Publication number Publication date
CN112839655B (zh) 2025-11-25
TW202430520A (zh) 2024-08-01
US20200115362A1 (en) 2020-04-16
EP3863635A1 (en) 2021-08-18
AU2019357618A1 (en) 2021-04-29
TW202027748A (zh) 2020-08-01
AR116694A1 (es) 2021-06-02
CN112839655A (zh) 2021-05-25
JP2022504620A (ja) 2022-01-13
JP2025041602A (ja) 2025-03-26
EP3863635A4 (en) 2022-06-15
AU2019357618B2 (en) 2025-04-24
WO2020077123A1 (en) 2020-04-16
TWI840423B (zh) 2024-05-01
US20220348561A1 (en) 2022-11-03
CA3114015A1 (en) 2020-04-16
TWI884745B (zh) 2025-05-21
JP7595004B2 (ja) 2024-12-05
US11203587B2 (en) 2021-12-21

Similar Documents

Publication Publication Date Title
MA53448A (fr) Composés agonistes des récepteurs bêta des hormones thyroïdiennes
IL282076A (en) Thyroid hormone receptor agonists
EP4017875A4 (en) THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
EP3863635A4 (en) Thyroid hormone receptor beta agonist compounds
EP4028008A4 (en) THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
EP4069686A4 (en) GPP-1 RECEPTOR AGONISTS
IL283362A (en) Thrβ receptor agonist compound and preparation method and use thereof
EP4301357A4 (en) Thyroid hormone receptor beta agonist compounds
PT3807267T (pt) Agonistas do recetor da hormona da tiroide e usos dos mesmos
EP4036090A4 (en) CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF
MA52642A (fr) Composés ciblant des récepteurs hormonaux nucléaires anticancéreux
DK3820873T3 (da) Selektive østrogenreceptornedbrydere
DK3762380T3 (da) Phenylpyrrolidinon-formylpeptid-2-receptoragonister
DK3810201T3 (da) GIP/GLP1-agonist-sammensætninger
SG11202102162RA (en) Anti-trem-2 agonist antibodies
IL260318A (en) A triple agonist for glucagon/glp-1/gip receptors
IL304460A (en) Estrogen receptor-modulating compounds
PL3774862T3 (pl) Nowe analogi glp-1
DK3820874T3 (da) Selektive estrogenreceptornedbrydere
IL280367A (en) CD226 agonist antibodies
EP3406264A4 (en) COMPOSITION WITH GLP-1 RECEPTOR AGONISTS AND GLUCAGON RECEPTOR AGONIST AND USE THEREOF
IL280199A (en) Receptor for vista
EP3720445A4 (en) BETA 2 SELECTIVE ADRENERGIC RECEPTOR AGONISTS
GB201816639D0 (en) GLP-1 Receptor Antagonist
IL277243A (en) Inverted pyrazoles are FFA4/GPR120 receptor agonists